Is there a new role for EGFR inhibitors in the treatment of lung cancer? In this expert column, Dr. Neil and Dr. Heist review the latest data. Medscape Hematology-Oncology
Identification of sporadic mismatch repair (MMR)-defective tumors is central to improved prognostication. Can clinicopathologic criteria be used to select sporadic tumors for evaluation of MMR status? American Journal of Clinical Pathology
For men aged 70 years and older with prostate cancer but without major co-morbidities and who have a life expectancy of at least 10 years, radical retropubic prostatectomy (RRP) is "a real option," a New York investigator told Reuters Health. Reuters Health Information
Five genetic risk markers might help identify men at the highest risk for a diagnosis of prostate cancer and help tailor and individualize screening. Medscape Medical News